Article Information
- Received September 2, 2014
- Revision received December 17, 2014
- Accepted December 27, 2014
- First published February 18, 2015.
- Version of record published February 18, 2015.
Author Information
- 1Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford OX1 9DU, United Kingdom,
- 2Department of Experimental Psychology, University of Oxford, Oxford OX1 2JD, United Kingdom,
- 3Department of Psychology, Royal Holloway, University of London, Surrey TW20 0EX, United Kingdom, and
- 4Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224
Author contributions
Author contributions: M.A.J.A., E.L., and N.R. designed research; M.A.J.A. performed research; M.A.J.A. contributed unpublished reagents/analytic tools; M.A.J.A. and N.R. analyzed data; M.A.J.A., E.L., and N.R. wrote the paper.
Disclosures
- Received September 2, 2014.
- Revision received December 17, 2014.
- Accepted December 27, 2014.
This work was supported by an ESRC 1+3 PhD Studentship to M.A.J.A., supervised by NR. We thank Ari Lingeswaran for help with MRI data collection; and Eden Hardmann and Arleta Woznica for acting as confederates.
The authors declare no competing financial interests.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
- Correspondence should be addressed to Dr. Matthew A.J. Apps, Nuffield Department of Clinical Neurosciences Level 6, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom. matthew.apps{at}ndcn.ox.ac.uk
Online Impact
